Bilateral Meetings
- Thursday (1:30pm – 6:00pm)
- Friday (9:00am – 12:00pm)
- Single point of access to the right expertise and facilities
- Expedites the development process
- Access to large and diverse clinical patient cohorts
Cutting edge infrastructure and expertise along the entire translational value chain
The EATRIS consortium of academic institutes provides cutting edge infrastructure and expertise along the entire translational value chain. Benefit from our ‘One-Stop Shop’ access to reach first-in-human application and on to clinical proof-of-concept in our five interrelated, highly specialized product areas.
With top quality facilities for basic research, manufacture, non-clinical and clinical development, our EATRIS institutes offer a truly multidisciplinary environment including patient cohorts and key opinion leader interaction. Take advantage of a comprehensive infrastructure for the following product classes:
Advanced Therapy Medicinal Products (ATMP)
Biomarkers
Imaging and Tracing
Small Molecules
Vaccines
- Technical co-operation
- Outsourcing co-operation
European network of expert partners to provide essential input to your translational strategy
In addition, EATRIS C&S provides access to a European network of expert partners, available to provide essential input to your translational strategy. They offer advice and capacity for:
Translational review of project including confirmation of unmet medical need, clear end product envisaged, innovative character and IP clarity (link to core process/access EATRIS).
Identifying the optimal regulatory strategy during translational development including performance of EMA Scientific Advice preparation & follow-up, clinical trial document preparation, application procedure handling and deadline monitoring via the EATRIS Regulatory and knowledge centres.
Input of clinical specialists into your development programme.
Access to large and diverse patient groups.
- Outsourcing co-operation
- Technical co-operation